 |
|
| FriendFeed is the easiest way to share online. Learn more » |
RT @GENbio: #Organovo Raises $6.5M to Advance #3-D #Tissue #Printing Platform http://www.genengnews.com/gen-new...
CureXcell™, a cell based therapy for hard to heal wounds by MacroCure, produced by Virtual Point - http://www.youtube.com/watch...
  |
...$ATHX, $NBS, $BPAX, $STEM, $GERN, $TNGN, & $VSTM tomorrow #bioceo2012 #celltherapy #stemcell #regenerativemedicine (2/2)
RT @FareedZakaria: Nearly 21% of American children live in #poverty, @MittRomney. You need to worry about this: http://globalpublicsquare.blogs.cnn.com/2012...
Stem Cells and the Lawsuit That May Shape Our Medical Future - Forbes http://www.forbes.com/sites.... From http://www.celltherapyblog to Forbes...
RT @Madrigal__: EMA's CAT Stakeholders Workshop (12th January 2012) - Presentations are now online http://www.ema.europa.eu/ema... #ATMP #stemcells
RT @LifeSciVC: Bridging The Real Gap in Biotech Venture Funding: the Elusive Series B. Its the toughest round to raise http://lifescivc.com/2012...
RT @BioSpace365: Cytomedix Inc Picks Up Aldagen Inc for $40 Million http://www.biospace.com/News... #biopharma #biotech
Curious whether Mills ($OSIR) will try to treat this as cancellation of entire agreement for Prochymal & Chondrogen pipeline or just GvHD
"The agreement provides that in this instance all rights to Prochymal revert back to Osiris without compensation to Sanofi" $OSIR $SNY
"Osiris has advised Sanofi that Osiris is treating these public statements as Sanofi's election to terminate the agreement"
"The statement issued by Sanofi was made without consultation with or knowledge of Osiris."
Things just got interesting b/n $OSIR + Sanofi. Mills issued a stmt saying Sanofi's announcement was news to him http://www.osiris.com/pdf...
If western foreign policy is driven by even a hint of humanitarianism, something must be done about this Syrian atrocity. Enough is enough.
Sanofi ($SNY) quietly drops Genzyme-Osiris ($OSIR) phase III GvHD program for Prochymal http://sanofi.mediaroom.com/index... (credit @henryw09)
Congratulations to @EdLField and $Aldagen investors in getting a long-sought deal done. http://www.genengnews.com/gen-new... http://www.scimitarequity.com/blog...
Geron: Mea Culpa http://seekingalpha.com/article.... Getting out of hESCs was business. The shameful payouts are just plain wrong. $GERN
RT @scientre: FDA tells sperm donor 2 cease manufacturing http://www.fda.gov/biologi... + interesting bkgd on donor http://nymag.com/print...
RT @bloodcure: Platelet Rich Plasma beats Cortisone for Plantar Fasciitis (Foot Pain) 94 vs 58 @ 12 months p = 0.001 http://plateletrichplasma.blogspot.com/
Updated list of industry-sponsored ph III or II/III cell therapy trials. 42% autologous. 21% oncology. Only 30% using a stem/progenitor cell
Updated list of industry-sponsored ph III or II/III cell therapy trials. 33 trials. 25 companies. >6,000 pts http://celltherapyblog.blogspot.com/2011...
IOM Coming Up Short so Far on Independent Analysis of the California Stem Cell Agency? http://californiastemcellrepor...
RT @Sistemic: Breaking News - Sistemic to work with TiGenix on landmark rheumatoid arthritis cell therapy product http://www.b3cnewswire.com/2012020...
Other ways to read this feed:
